Literature DB >> 11044123

Thogoto virus matrix protein is encoded by a spliced mRNA.

G Kochs1, F Weber, S Gruber, A Delvendahl, C Leitz, O Haller.   

Abstract

Thogoto virus (THOV) is a tick-transmitted orthomyxovirus with a segmented, negative-stranded RNA genome. In this study, we investigated the coding strategy of RNA segment 6 and found that it contains 956 nucleotides and codes for the matrix (M) protein. The full-length cDNA contains a single, long reading frame that lacks a stop codon but has coding capacity for a putative 35-kDa protein. In contrast, the M protein of THOV has an apparent molecular mass of 29 kDa as assessed by polyacrylamide gel electrophoresis. Therefore, we investigated the possibility of posttranscriptional processing of segment 6 transcripts by reverse transcription-PCR and identified a spliced mRNA that contains a stop codon and is translated into the 29-kDa M protein. Interestingly, the nontemplated UGA stop codon is generated by the splicing event itself. Thus, the unusual M coding strategy of THOV resembles that of Influenza C virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044123      PMCID: PMC110953          DOI: 10.1128/jvi.74.22.10785-10789.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Nucleotide sequence of the tick-borne orthomyxo-like Dhori/India/1313/61 virus membrane protein gene.

Authors:  W C Clay; F J Fuller
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

2.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

3.  Identification of a 374 amino acid protein encoded by RNA segment 6 of influenza C virus.

Authors:  S Hongo; P Gao; K Sugawara; Y Muraki; Y Matsuzaki; Y Tada; F Kitame; K Nakamura
Journal:  J Gen Virol       Date:  1998-09       Impact factor: 3.891

4.  Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons.

Authors:  G Whittaker; M Bui; A Helenius
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  The fourth genus in the Orthomyxoviridae: sequence analyses of two Thogoto virus polymerase proteins and comparison with influenza viruses.

Authors:  M B Leahy; J T Dessens; F Weber; G Kochs; P A Nuttall
Journal:  Virus Res       Date:  1997-08       Impact factor: 3.303

6.  Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins.

Authors:  M Bui; G Whittaker; A Helenius
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Influenza C virus CM2 protein is produced from a 374-amino-acid protein (P42) by signal peptidase cleavage.

Authors:  S Hongo; K Sugawara; Y Muraki; Y Matsuzaki; E Takashita; F Kitame; K Nakamura
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein.

Authors:  K Watanabe; H Handa; K Mizumoto; K Nagata
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence.

Authors:  A Pekosz; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins.

Authors:  F Weber; G Kochs; S Gruber; O Haller
Journal:  Virology       Date:  1998-10-10       Impact factor: 3.616

View more
  12 in total

1.  Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.

Authors:  Alexej Dick; Laura Graf; Daniel Olal; Alexander von der Malsburg; Song Gao; Georg Kochs; Oliver Daumke
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

2.  Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus.

Authors:  Corinna Patzina; Otto Haller; Georg Kochs
Journal:  J Biol Chem       Date:  2014-01-21       Impact factor: 5.157

3.  Rescue of recombinant Thogoto virus from cloned cDNA.

Authors:  E Wagner; O G Engelhardt; S Gruber; O Haller; G Kochs
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection.

Authors:  Jan Spitaels; Lien Van Hoecke; Kenny Roose; Georg Kochs; Xavier Saelens
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

5.  Genomic and antigenic characterization of Jos virus.

Authors:  Ana Valeria Bussetti; Gustavo Palacios; Amelia Travassos da Rosa; Nazir Savji; Komal Jain; Hilda Guzman; Stephen Hutchison; Vsevolod L Popov; Robert B Tesh; W Ian Lipkin
Journal:  J Gen Virol       Date:  2011-10-12       Impact factor: 3.891

6.  Comparative Study of Ten Thogotovirus Isolates and Their Distinct In Vivo Characteristics.

Authors:  Jonas Fuchs; Kevin Lamkiewicz; Larissa Kolesnikova; Martin Hölzer; Manja Marz; Georg Kochs
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

7.  Upolu virus and Aransas Bay virus, two presumptive bunyaviruses, are novel members of the family Orthomyxoviridae.

Authors:  Thomas Briese; Rashmi Chowdhary; Amelia Travassos da Rosa; Stephen K Hutchison; Vsevolod Popov; Craig Street; Robert B Tesh; W Ian Lipkin
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB.

Authors:  Carola Vogt; Ellen Preuss; Daniel Mayer; Friedemann Weber; Martin Schwemmle; Georg Kochs
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

9.  Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist.

Authors:  Kathrin Hagmaier; Stephanie Jennings; Johanna Buse; Friedemann Weber; Georg Kochs
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Viral targeting of TFIIB impairs de novo polymerase II recruitment and affects antiviral immunity.

Authors:  Darya A Haas; Arno Meiler; Katharina Geiger; Carola Vogt; Ellen Preuss; Georg Kochs; Andreas Pichlmair
Journal:  PLoS Pathog       Date:  2018-04-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.